Connect Biopharma Holdings Ltd Annual Research And Development Expense in CNY from 2019 to 2022

Taxonomy & unit
ifrs-full: CNY and USD
Summary
Connect Biopharma Holdings Ltd annual Research And Development Expense history and growth rate from 2019 to 2022.
  • Connect Biopharma Holdings Ltd annual Research And Development Expense for 2022 was ¥652M, a 25.9% increase from 2021.
  • Connect Biopharma Holdings Ltd annual Research And Development Expense for 2021 was ¥518M, a 243% increase from 2020.
  • Connect Biopharma Holdings Ltd annual Research And Development Expense for 2020 was ¥151M, a 41.8% increase from 2019.
Research And Development Expense, Annual (CNY)
Research And Development Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 652M +134M +25.9% Jan 1, 2022 Dec 31, 2022 20-F 2023-04-11
2021 518M +367M +243% Jan 1, 2021 Dec 31, 2021 20-F 2023-04-11
2020 151M +44.5M +41.8% Jan 1, 2020 Dec 31, 2020 20-F 2023-04-11
2019 106M Jan 1, 2019 Dec 31, 2019 20-F 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.